Dear AuntMinnie Member,
The votes are in, and we're proud to announce the winners in this year's edition of the Minnies, our annual awards event recognizing the best and brightest in medical imaging!
The winners emerged from over 200 candidates in 15 categories after two rounds of voting by our expert panel. Did your favored candidates win? You can find out by reading our article profiling this year's awardees.
PET/CT in prostate cancer patients
A new study by researchers at the U.S. National Cancer Institute has concluded that PET/CT imaging offers significant value in characterizing prostate cancer lesions that have spread to the bone. After performing PET/CT with the radiopharmaceutical F-18 DCFPyL on indeterminate bone lesions in these patients, the researchers found that certain findings in these studies were an effective method of determining whether these lesions were benign or malignant.
Our coverage of the NCI research was one of our most highly viewed stories of the week, and you can access it by clicking here or by visiting our Molecular Imaging Community.
Coverage from ASTRO 2022
Our coverage of the annual meeting of the American Society for Radiation Oncology (ASTRO) was also popular this week among AuntMinnie.com members. Check out our articles on the following:
- How palliative radiation therapy for high-risk, asymptomatic bone metastases could potentially prolong a patient's life.
- How an AI model trained using fitness tracker data could predict if patients undergoing chemoradiation may need hospitalization.
- How flash radiation treatment with protons could be a practical means of reducing pain.
For these and other stories from ASTRO, visit our Radiation Oncology Community.
